MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000355219

Медицинская библиотека · Case reports in oncology · 2013

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.

Kadowaki Shigenori, Yatabe Yasushi, Hirakawa Hitoshi, Komori Azusa, Kondoh Chihiro, Hasegawa Yasuhisa, Muro Kei

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Carcinoma ex pleomorphic adenoma (CXPA) of the salivary glands has often a salivary duct carcinoma (SDC) component, which resembles ductal carcinoma of the breast and frequently overexpresses human epidermal growth factor receptor-2 (HER2). We report a case of metastatic CXPA with SDC component who was treated with trastuzumab-based chemotherapy and has had a durable complete response.

CASE REPORT: A 74-year-old man was diagnosed with CXPA of the right parotid gland. The resected tumor was histologically diagnosed as CXPA with a predominant SDC component that showed strong positivity for HER2 protein and HER2 gene amplification. Multiple pulmonary metastatic lesions were detected after surgery, and combination chemotherapy with paclitaxel and trastuzumab was initiated. A complete response was confirmed after 7 treatment cycles, and no evidence of disease progression has been observed after 13 months of initiation of therapy.

CONCLUSIONS

This report suggests a potential utility of trastuzumab-based chemotherapy for HER2-positive CXPA.

Для цитирования: Kadowaki Shigenori, Yatabe Yasushi, Hirakawa Hitoshi, Komori Azusa, Kondoh Chihiro, Hasegawa Yasuhisa, Muro Kei. Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.. Case reports in oncology. 2013. DOI: 10.1159/000355219.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.